JD Health Strengthens Vertical Specialization to Unlock New Pathways in Health Services

Recently, JD Health made a prominent appearance at key industry conferences. As the preferred partner for pharmaceutical and healthcare enterprises undergoing digital transformation, JD Health was invited to attend multiple forums, where it shared its strategic layouts and practical experiences in recent years across several vertical sectors, including pediatric medication, menopause health, oncology drugs, and weight management. JD Health is continuously delving into segmented user needs, providing more precise health solutions through the deep integration of services and products, while simultaneously helping pharmaceutical companies reduce costs and improve efficiency, thereby promoting high-quality development in the pharmaceutical industry.

Currently, pediatric medications in China have long faced challenges such as a limited number of dedicated drug varieties, a scarcity of age-appropriate dosage forms, insufficient specifications, and a lack of specialized drugs. With parents’ growing attention to children’s health, the demand for online pediatric healthcare services and medications has seen explosive growth.

At the Child Health Growth Management Solutions Forum held during this conference, the head of JD Health’s pediatric supplementation business stated that JD Health currently offers more than 400 pediatric medications, comprehensively covering core areas such as respiratory, digestive, nutritional, dermatological, and rare diseases. The platform brings together original pediatric drugs, regionally specialized products, new and specialty medicines, and innovative traditional Chinese medicine (TCM) drugs, effectively addressing parents’ primary need to “find and purchase” these medications with ease. In 2024, JD Health’s pediatric business achieved a growth rate exceeding 40%, with its online market share for pediatric medications reaching 38.8%, making it the trusted platform of choice for numerous parents.

In terms of professional services, the Pediatric Center of JD Internet Hospital has assembled senior pediatric professors and chief physicians from renowned tertiary hospitals across China, covering core specialties such as child growth and development, respiratory allergies, digestive health and nutrition, neuropsychology, endocrinology (short stature/precocious puberty), child healthcare, ophthalmology, and otolaryngology. Leveraging a network of over 10,000 licensed pediatric experts available online, JD Health provides 24/7 free parenting consultation services. Meanwhile, JD Health collaborates closely with top-tier institutions such as Beijing Children’s Hospital to promote the accessibility of high-quality pediatric medical resources.

Authoritative data indicate that the average age at which Chinese women enter perimenopause is 46 years, with the average age of menopause ranging from 48 to 52 years. This substantial population not only experiences physiological changes such as declining ovarian function and fluctuating estrogen levels, but also bears multiple social pressures, including their children’s independence, career transitions, and caregiving for elderly relatives. These factors contribute to the frequent occurrence of symptoms such as hot flashes, night sweats, insomnia, and mood swings, significantly impairing their quality of life.

At the Menopause Health Management Solutions Forum of this conference, the head of JD Health’s digital marketing business shared insights into the health needs of menopausal women. She introduced that, in response to the complex and evolving health needs of menopausal women, JD Health leverages its strong platform advantages and abundant medical resources to provide comprehensive health solutions covering pharmaceuticals, health management services, and psychological interventions. In terms of physical health, JD Health offers a wide range of calcium supplements, vitamin D, and other nutritional supplements to address common issues such as osteoporosis and increased risk of cardiovascular disease among menopausal women, thereby meeting their daily healthcare needs. Sales of menopause-related medications on JD Health have continued to grow, with a year-on-year increase of 20% in 2024.

In the field of mental health, JD Health provides professional psychological counseling and stress-relief services to address common psychological issues among menopausal women, such as mood swings, anxiety, and depression, helping them alleviate psychological stress and improve their quality of life.

For cancer patients, particularly those seeking treatment outside their home regions and using novel specialty drugs, challenges such as “brief consultations in major cities followed by a lack of guidance upon returning home” are common. There are significant unmet needs in terms of drug accessibility, long-term medication management, and disease care.

At the forum on innovative drugs and patient management, the head of patient services at JD Health’s Pharmaceutical Business Division stated that JD Health enhances the accessibility of new specialty medications through its “Cloud DTP” model and provides patients with dedicated one-on-one in-depth pharmacist services, effectively filling the gap in long-term guidance beyond medical instructions. Currently, the service covers seven high-incidence and complex cancer types, including breast cancer and liver cancer. Over the past year, it has served 26,000 patients and their family members, including more than 8,000 breast cancer patients and their families.

Addressing the unique complexities of oncology pharmacotherapy—such as the need for precise control of blood drug concentrations, prolonged treatment cycles, and significant challenges in managing adverse reactions in adrenocortical carcinoma—JD Health has assembled a professional team comprising licensed pharmacists and specialist physicians to innovatively launch a “Multi-Role Private Domain Service Group” model. Under strict protection of patient privacy, this model provides users with personalized, end-to-end management: pharmacists closely monitor medication adherence, guide therapeutic drug monitoring, and promptly intervene against the risk of unauthorized discontinuation, thereby significantly enhancing treatment standardization and patient confidence.

Furthermore, JD Health has actively responded to the systemic rehabilitation needs of oncology patients. Taking breast cancer as an example, in addition to pharmacological treatment, patients have substantial needs in lifestyle management—including weight control, nutritional supplementation, and evidence-based exercise—as well as access to home-based health information and dietary guidance. JD Health is deeply integrating these comprehensive elements into its service ecosystem.

Currently, obesity has become a global health challenge. The latest data from the National Health Commission shows that more than half of the adult population faces weight-related health issues, with a trend toward affecting younger and even adolescent populations.

At the Summit on the Weight Management Ecosystem, the head of JD Health’s Cardiovascular, Cerebrovascular, Neurological, and Endocrinology Business Division stated that JD Health currently precisely addresses users’ core needs for convenient access to weight-loss medications, scientifically grounded professional guidance, and intelligent management, thereby constructing a comprehensive, end-to-end scientific weight-loss solution. Leveraging its nationwide network of 20 pharmaceutical cold-chain warehouses, JD Health has established a medication distribution network covering more than 400 cities, ensuring safe and controlled handling at every stage—from manufacturing to delivery—for popular weight-loss drugs such as semaglutide and tirzepatide. Additionally, JD Internet Hospital has launched a dedicated weight-management clinic, providing users with a full-process, science-based weight-loss service that includes risk assessment, personalized plan formulation, medication guidance, and regular follow-up visits.

In the face of numerous challenges confronting the pharmaceutical and health industries, JD Health has developed specialized products and service solutions within core vertical sectors, effectively addressing the health concerns of specific population segments and providing a benchmark for industry development. Looking ahead, JD Health will continue to leverage its strengths in supply chain management, healthcare services, and digital technology, further deepening its vertical integration while collaborating with partners to co-create an efficient, inclusive, and compassionate healthcare ecosystem.